instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Palpitations'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Sinus tachycardia'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Supraventricular tachycardia'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
What was the outcome of reaction 'Vomiting'? | Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use.
Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declin... | Recovered | ReactionOutcome | CC BY | 33854801 | 19,256,050 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.
The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented wi... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 33854804 | 19,249,781 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.
The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented wi... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 33854804 | 19,249,781 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.
The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented wi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33854804 | 19,249,781 | 2021 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.
The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented wi... | 1 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 33854804 | 19,249,781 | 2021 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.
The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented wi... | Fatal | ReactionOutcome | CC BY | 33854804 | 19,249,781 | 2021 |
What was the outcome of reaction 'Off label use'? | The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.
The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented wi... | Fatal | ReactionOutcome | CC BY | 33854804 | 19,249,781 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33855101 | 19,830,086 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | IMIPENEM, LINEZOLID | DrugsGivenReaction | CC BY-NC-ND | 33855101 | 19,810,533 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hemiparesis'. | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33855101 | 19,830,094 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33855101 | 19,830,093 | 2021-04 |
What was the administration route of drug 'CEFTRIAXONE'? | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33855101 | 19,830,123 | 2021-04 |
What was the administration route of drug 'IMIPENEM'? | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33855101 | 19,830,091 | 2021-04 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33855101 | 19,830,094 | 2021-04 |
What was the outcome of reaction 'Death'? | Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species.
Nocardial brain abscesses are rare, and published literature describing brain abscesses due to Nocardia species is limited to individual case reports or small series. We report one of the largest contemporary retrosp... | Fatal | ReactionOutcome | CC BY-NC-ND | 33855101 | 19,830,091 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33859486 | 20,303,517 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33859486 | 20,303,517 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33859486 | 20,303,517 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoglycaemia'. | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33859486 | 20,303,517 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33859486 | 20,303,517 | 2021 |
What was the outcome of reaction 'Abdominal pain'? | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | Recovered | ReactionOutcome | CC BY-NC | 33859486 | 20,303,517 | 2021 |
What was the outcome of reaction 'Diarrhoea'? | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | Recovered | ReactionOutcome | CC BY-NC | 33859486 | 20,303,517 | 2021 |
What was the outcome of reaction 'Drug intolerance'? | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | Recovering | ReactionOutcome | CC BY-NC | 33859486 | 20,193,882 | 2021 |
What was the outcome of reaction 'Hypoglycaemia'? | Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA.
Hypoglycemia presents relatively typical symptoms. However, when it occurs spontaneously - like in insulin autoimmune syndrome - it is difficult to perform scheduled biochemical tests at the laboratory. The study presents the case of a 31-year-old Caucasian fema... | Recovering | ReactionOutcome | CC BY-NC | 33859486 | 20,303,517 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'BK virus infection'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Engraft failure'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | FILGRASTIM | DrugsGivenReaction | CC BY | 33859695 | 19,740,676 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease'? | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | Fatal | ReactionOutcome | CC BY | 33859695 | 19,740,676 | 2021 |
What was the outcome of reaction 'Chronic graft versus host disease'? | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | Fatal | ReactionOutcome | CC BY | 33859695 | 19,740,676 | 2021 |
What was the outcome of reaction 'Death'? | A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies.
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have... | Fatal | ReactionOutcome | CC BY | 33859695 | 19,740,676 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute coronary syndrome'. | Effect of age on dexmedetomidine treatment for ventilated patients with sepsis: a post-hoc analysis of the DESIRE trial.
There are no definitive data to determine whether age influences the effects of dexmedetomidine (DEX) treatment. Thus, we investigated whether older age was associated with more favorable sedative ac... | DEXMEDETOMIDINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33859826 | 19,360,706 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Cutaneous Vasculopathy in a COVID-19 Critically Ill Patient: A Histologic, Immunohistochemical, and Electron Microscopy Study.
We describe a critically ill, SARS-CoV-2 positive patient with respiratory failure and thrombotic/livedoid skin lesions, appearing during the course of the disease. The biopsy of the lesions re... | AZITHROMYCIN, CEFTAROLINE, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33859845 | 19,277,999 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperkalaemia'. | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | MELPHALAN, MYCOPHENOLATE MOFETIL, NIVOLUMAB | DrugsGivenReaction | CC BY | 33859852 | 19,280,909 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | MELPHALAN, MYCOPHENOLATE MOFETIL, NIVOLUMAB | DrugsGivenReaction | CC BY | 33859852 | 19,280,909 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | MELPHALAN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33859852 | 19,260,786 | 2021 |
What was the administration route of drug 'MELPHALAN'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Other | DrugAdministrationRoute | CC BY | 33859852 | 19,280,909 | 2021 |
What was the administration route of drug 'MYCOPHENOLATE MOFETIL'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33859852 | 19,280,909 | 2021 |
What was the dosage of drug 'MELPHALAN HYDROCHLORIDE'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | 4 CYCLES FOR 6 MONTH PERIOD. | DrugDosageText | CC BY | 33859852 | 19,260,786 | 2021 |
What was the dosage of drug 'MELPHALAN'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | HIGH DOSE | DrugDosageText | CC BY | 33859852 | 19,280,909 | 2021 |
What was the dosage of drug 'NIVOLUMAB'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | 3 MILLIGRAM/KILOGRAM, Q2WK | DrugDosageText | CC BY | 33859852 | 19,255,811 | 2021 |
What was the outcome of reaction 'Acute hepatic failure'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Fatal | ReactionOutcome | CC BY | 33859852 | 19,260,786 | 2021 |
What was the outcome of reaction 'Cardio-respiratory arrest'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Fatal | ReactionOutcome | CC BY | 33859852 | 19,280,909 | 2021 |
What was the outcome of reaction 'Hepatitis'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Fatal | ReactionOutcome | CC BY | 33859852 | 19,280,909 | 2021 |
What was the outcome of reaction 'Hyperkalaemia'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Fatal | ReactionOutcome | CC BY | 33859852 | 19,280,909 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Immune checkpoint inhibitors, such as nivolumab, a programmed death receptor-1 (PD-1) inhibitor, have dramatically improved the treatment of advanced melanomas. Chemosaturation ... | Fatal | ReactionOutcome | CC BY | 33859852 | 19,280,909 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of two different histological components, one of which is of a neuroendocrine origin. Given its suggested... | CARBOPLATIN, ETOPOSIDE, GEMCITABINE, PACLITAXEL, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33859853 | 19,263,366 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of two different histological components, one of which is of a neuroendocrine origin. Given its suggested... | CARBOPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 33859853 | 19,288,411 | 2021 |
What was the dosage of drug 'ETOPOSIDE'? | A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of two different histological components, one of which is of a neuroendocrine origin. Given its suggested... | 2 CYCLES | DrugDosageText | CC BY | 33859853 | 19,263,366 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of two different histological components, one of which is of a neuroendocrine origin. Given its suggested... | THIRD?LINE | DrugDosageText | CC BY | 33859853 | 19,263,366 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of two different histological components, one of which is of a neuroendocrine origin. Given its suggested... | 3 CYCLES | DrugDosageText | CC BY | 33859853 | 19,263,366 | 2021 |
What was the outcome of reaction 'Neoplasm progression'? | A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature.
Mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs) are rare tumors composed of two different histological components, one of which is of a neuroendocrine origin. Given its suggested... | Fatal | ReactionOutcome | CC BY | 33859853 | 19,288,411 | 2021 |
What was the dosage of drug 'LEUCOVORIN CALCIUM'? | Bisegmentectomy and venous reconstruction after portal vein embolization for the remnant hemiliver in a patient with recurrent colorectal liver metastases.
Repeat hepatectomy for recurrent colorectal liver metastases (CRLM) for the remnant hemiliver is sometimes challenging due to the insufficient future liver remnant ... | UNK, CYCLIC | DrugDosageText | CC BY | 33860147 | 19,447,741 | 2021-03 |
What was the dosage of drug 'LEUCOVORIN'? | Bisegmentectomy and venous reconstruction after portal vein embolization for the remnant hemiliver in a patient with recurrent colorectal liver metastases.
Repeat hepatectomy for recurrent colorectal liver metastases (CRLM) for the remnant hemiliver is sometimes challenging due to the insufficient future liver remnant ... | PART OF MFOLFOX6 REGIMEN | DrugDosageText | CC BY | 33860147 | 19,638,601 | 2021-03 |
What was the dosage of drug 'PANITUMUMAB'? | Bisegmentectomy and venous reconstruction after portal vein embolization for the remnant hemiliver in a patient with recurrent colorectal liver metastases.
Repeat hepatectomy for recurrent colorectal liver metastases (CRLM) for the remnant hemiliver is sometimes challenging due to the insufficient future liver remnant ... | UNK, CYCLIC | DrugDosageText | CC BY | 33860147 | 19,447,741 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | ALPROSTADIL ALFADEX, ASPIRIN, DOXAPRAM, NICARDIPINE, PROPOFOL, REMIFENTANIL, ROCURONIUM BROMIDE, SUGAMMADEX | DrugsGivenReaction | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | ALPROSTADIL ALFADEX, ASPIRIN, DOXAPRAM, NICARDIPINE, PROPOFOL, REMIFENTANIL, ROCURONIUM BROMIDE, SUGAMMADEX | DrugsGivenReaction | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
What is the weight of the patient? | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | 47 kg. | Weight | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
What was the administration route of drug 'REMIFENTANIL'? | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | Intravenous drip | DrugAdministrationRoute | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
What was the dosage of drug 'DOXAPRAM'? | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | 40 mg (milligrams). | DrugDosage | CC BY | 33863374 | 19,285,025 | 2021-04-17 |
What was the dosage of drug 'NICARDIPINE'? | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | 1?0.5 MG/HR | DrugDosageText | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
What was the dosage of drug 'REMIFENTANIL'? | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | INDUCTION ANAESTHESIA | DrugDosageText | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
What was the outcome of reaction 'Hypertension'? | Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
BACKGROUND
Malignant hyperthermia (MH) is a rare genetic disease characterized by the development of ve... | Recovered | ReactionOutcome | CC BY | 33863374 | 19,281,766 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | BUPROPION, CLOZAPINE, FLUPHENAZINE, NICOTINE, OLANZAPINE, QUETIAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 33863375 | 19,304,646 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | ARIPIPRAZOLE, BUPROPION, CLOZAPINE, FLUPHENAZINE, NICOTINE, OLANZAPINE, QUETIAPINE FUMARATE, RISPERIDONE | DrugsGivenReaction | CC BY | 33863375 | 19,289,147 | 2021-04-17 |
What was the administration route of drug 'ARIPIPRAZOLE'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Oral | DrugAdministrationRoute | CC BY | 33863375 | 19,289,147 | 2021-04-17 |
What was the administration route of drug 'CLOZAPINE'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Oral | DrugAdministrationRoute | CC BY | 33863375 | 19,289,147 | 2021-04-17 |
What was the administration route of drug 'OLANZAPINE'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Oral | DrugAdministrationRoute | CC BY | 33863375 | 19,289,147 | 2021-04-17 |
What was the administration route of drug 'QUETIAPINE FUMARATE'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Oral | DrugAdministrationRoute | CC BY | 33863375 | 19,289,147 | 2021-04-17 |
What was the administration route of drug 'QUETIAPINE'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Oral | DrugAdministrationRoute | CC BY | 33863375 | 19,304,646 | 2021-04-17 |
What was the administration route of drug 'RISPERIDONE'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Oral | DrugAdministrationRoute | CC BY | 33863375 | 19,289,147 | 2021-04-17 |
What was the outcome of reaction 'Dysphemia'? | Clozapine-induced stuttering in the absence of known risk factors: a case report.
BACKGROUND
Stuttering is a rare side effect of clozapine. It has been shown to occur in the presence of one or more factors such as abnormal electrophysiological findings and seizures, extrapyramidal symptoms, brain pathology, and a famil... | Recovered | ReactionOutcome | CC BY | 33863375 | 19,265,139 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial.
To determine the non-inferiority of nurse-led care (NLC) in patients with anticitrullinated protein antibody (ACPA)-positive and/or rheum... | LEFLUNOMIDE | DrugsGivenReaction | CC BY-NC | 33863842 | 19,579,181 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial.
To determine the non-inferiority of nurse-led care (NLC) in patients with anticitrullinated protein antibody (ACPA)-positive and/or rheum... | LEFLUNOMIDE | DrugsGivenReaction | CC BY-NC | 33863842 | 19,579,181 | 2021-04 |
What was the outcome of reaction 'Acute kidney injury'? | Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial.
To determine the non-inferiority of nurse-led care (NLC) in patients with anticitrullinated protein antibody (ACPA)-positive and/or rheum... | Fatal | ReactionOutcome | CC BY-NC | 33863842 | 19,579,181 | 2021-04 |
What was the outcome of reaction 'Infection'? | Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial.
To determine the non-inferiority of nurse-led care (NLC) in patients with anticitrullinated protein antibody (ACPA)-positive and/or rheum... | Fatal | ReactionOutcome | CC BY-NC | 33863842 | 19,579,181 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cushingoid'. | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33863937 | 20,154,180 | 2021-04-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis haemorrhagic'. | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33863937 | 20,154,180 | 2021-04-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33863937 | 20,154,180 | 2021-04-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomembranous colitis'. | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33863937 | 20,154,179 | 2021-04-16 |
What was the administration route of drug 'ALPROSTADIL'? | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33863937 | 20,153,944 | 2021-04-16 |
What was the administration route of drug 'CYCLOSPORINE'? | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | Oral | DrugAdministrationRoute | CC BY | 33863937 | 20,153,938 | 2021-04-16 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33863937 | 20,153,944 | 2021-04-16 |
What was the administration route of drug 'PREDNISOLONE'? | Clinical presentations and long term prognosis of childhood onset polyarteritis nodosa in single centre of Korea.
Childhood-onset polyarteritis nodosa (PAN) is a rare and systemic necrotising vasculitis in children affecting small- to medium-sized arteries. To date, there have been only a few reports because of its rar... | Oral | DrugAdministrationRoute | CC BY | 33863937 | 20,153,944 | 2021-04-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriospasm coronary'. | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | NITROUS OXIDE, PROPOFOL, REMIFENTANIL, ROCURONIUM BROMIDE, SEVOFLURANE, SUCCINYLCHOLINE CHLORIDE | DrugsGivenReaction | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrioventricular block'. | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | NITROUS OXIDE, PROPOFOL, REMIFENTANIL, ROCURONIUM BROMIDE, SEVOFLURANE, SUCCINYLCHOLINE CHLORIDE | DrugsGivenReaction | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram ST segment elevation'. | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | NITROUS OXIDE, PROPOFOL, REMIFENTANIL, ROCURONIUM BROMIDE, SEVOFLURANE, SUCCINYLCHOLINE CHLORIDE | DrugsGivenReaction | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What is the weight of the patient? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | 12.2 kg. | Weight | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What was the administration route of drug 'ROCURONIUM BROMIDE'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | Intravenous bolus | DrugAdministrationRoute | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.